COMPOSITIONS AND METHODS FOR TREATING MYASTHENIA GRAVIS

Disclosed herein are methods of treatment for myasthenia gravis (MG) that involve administering (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid, or a pharmaceutical composition thereof, to a patient suffering from symptoms of MG. Pharmaceutical compositions and kits-to-parts including (2S)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BOLD, Jane Mary, CHIN, Eva Rose, KNUTSEN, Lars J.S, NORDHOLM, Lars, JENSEN, Klaus Gjervig, GRØNNEBÆK, Thomas Skjærlund, HUTCHISON, John Blundell, BASTIAS, Jorge Armando Quiroz, KELLY, Nicholas Michael, NIELSEN, Ole Bækgaard, FLAGSTAD, Peter, PEDERSEN, Thomas Holm
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed herein are methods of treatment for myasthenia gravis (MG) that involve administering (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid, or a pharmaceutical composition thereof, to a patient suffering from symptoms of MG. Pharmaceutical compositions and kits-to-parts including (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid are also disclosed. L'invention concerne des méthodes de traitement de la myasthénie grave (MG) qui impliquent l'administration d'acide (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phénoxy]propanoïque, ou d'une composition pharmaceutique de celui-ci, à un patient souffrant de symptômes de MG. L'invention concerne également des compositions pharmaceutiques et des kits à parties comprenant de l'acide (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phénoxy]propanoïque.